Rare disease commercial leads at mid-size pharma
MOA + disease overview combo for HCP detailing and field team slides.
Rare Disease
Animation for rare disease programs
Rare disease audiences are scientific and emotional at the same time. Patients, families, advocates, clinicians, and investors all need a clear story: what the disease is, what your therapy does, why it matters. CDI Studio builds animations for small and mid-size biotech and pharma teams that thread that needle with scientific precision and human empathy.
Empathy-first
Storyboarding workflow
Caregiver tested
Clarity reviewed by patient advocates where possible
Multi-language ready
Master delivery suited to localization
What we build
- Disease etiology and progression animations
- Enzyme replacement therapy MOA videos
- Substrate reduction and chaperone therapy mechanism animations
- Gene therapy for rare disease (mostly AAV)
- Patient and caregiver education explainers
- Advocacy and disease-awareness campaign animations
Who briefs us
Patient advocacy partners at biotech
Plain-language explainers for caregivers and newly diagnosed patients.
Medical affairs
Disease-state animations for CME and continuing professional development programs.
Common formats
Disease + MOA combo
Multi-scene piece pairing disease etiology with treatment mechanism. Scoped at discovery if it runs longer than the standard 30 to 60 seconds.
Patient explainer
Standard 30 to 60 second piece, accessible language with clear analogies for non-clinical audiences.
Advocacy campaign asset
Short social-first vertical cut for awareness drives and rare disease day.
Frequently asked
Do you work with patient advocacy organizations?
Yes. We have collaborated with advocacy partners as scientific reviewers for accessible-language sections.
Can the same piece serve clinical and patient audiences?
Often we deliver two cuts from one production: a clinical cut with technical labels, and a patient cut with simplified narration.
Ready to start?
Send us your science, target audience, and deadline. We will scope and price within 48 hours.